内皮FKBP5的S-亚硝基化通过PHLPP-AKT轴抑制缺血性脑卒中血管新生
研究在雄性小鼠短暂大脑中动脉闭塞模型及氧糖剥夺/复氧内皮细胞中,用S-亚硝基化蛋白质组学发现FKBP5半胱氨酸339位点修饰增加。C339A突变可恢复内皮增殖迁移成管,内皮靶向表达FKBP5-C339A促进血管新生与感觉运动恢复。机制为S-亚硝基化增强FKBP5与PHLPP结合、抑制AKT磷酸化。
要点
- 缺血脑组织及氧糖剥夺/复氧内皮细胞中S-亚硝基化FKBP5增加,总FKBP5不变。
- C339A突变阻止FKBP5 S-亚硝基化,恢复内皮血管新生能力。
- 内皮靶向FKBP5-C339A促血管新生、减少损伤并改善慢性感觉运动恢复。
核心结论
- 内皮FKBP5是卒中后血管再生的新调节因子,C339位点S-亚硝基化通过PHLPP依赖抑制AKT信号限制血管新生和功能恢复。
研究设计与样本
- 8周龄雄性小鼠行短暂大脑中动脉闭塞,脑微血管内皮细胞行氧糖剥夺/复氧,进行S-亚硝基化蛋白质组学。
- 用半胱氨酸突变和生物素转换实验验证修饰位点,在内皮血管新生实验中比较野生型与C339A突变FKBP5。
- 4周龄雄性小鼠接受内皮靶向AAV9编码野生型或C339A突变FKBP5,4周后行短暂大脑中动脉闭塞,评估至第28天。
主要发现
- 缺血脑组织和氧糖剥夺/复氧内皮细胞中S-亚硝基化FKBP5增加,诱导型一氧化氮合酶为上游介导者。
- 质谱和突变确定半胱氨酸339为主要修饰位点,C339A阻止S-亚硝基化并恢复内皮增殖、迁移、出芽和成管。
- 小鼠内皮靶向FKBP5-C339A促进梗死周围血管新生和灌注、减少组织损伤、改善慢性感觉运动恢复。
- S-亚硝基化增强FKBP5与PHLPP结合并降低AKT磷酸化,C339A减弱该结合并恢复AKT活化。
- PHLPP抑制剂NSC117079增强体外AKT信号和血管新生反应。
临床怎么用
- 靶向内皮FKBP5 C339位点S-亚硝基化可能成为增强缺血性脑卒中后血管修复的策略。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Angiogenesis contributes to vascular repair and functional recovery after ischemic stroke, yet how nitric oxide-mediated S-nitrosylation shapes this response remains unclear. We investigated the role of S-nitrosylation in postischemic angiogenesis and the underlying molecular mechanism. METHODS: S-nitrosylation proteomics was performed in ischemic brain tissue from 8-week-old male mice subjected to transient middle cerebral artery occlusion and in brain microvascular endothelial cells exposed to oxygen-glucose deprivation/reoxygenation. Candidate modification sites were validated by cysteine mutagenesis and biotin-switch assays. Wild-type and C339A-mutant FKBP5 (FK506-binding protein 5) were compared in endothelial angiogenesis assays. Four-week-old male mice received endothelial-targeted adeno-associated virus 9 encoding wild-type or C339A-mutant FKBP5 and underwent transient middle cerebral artery occlusion 4 weeks later. Vascular and neurological outcomes were assessed through day 28. Protein-interaction and signaling analyses defined the downstream mechanism. RESULTS: S-nitrosylated FKBP5, but not total FKBP5, was increased in ischemic brain tissue and oxygen-glucose deprivation/reoxygenation-treated endothelial cells; inducible nitric oxide synthase was an upstream mediator. Mass spectrometry and mutagenesis identified cysteine 339 as the predominant modification site. C339A prevented FKBP5 S-nitrosylation and rescued endothelial proliferation, migration, sprouting, and tube formation after oxygen-glucose deprivation/reoxygenation. In mice, endothelial-targeted expression of FKBP5-C339A promoted peri-infarct angiogenesis and perfusion, reduced tissue injury, and improved chronic sensorimotor recovery. Mechanistically, S-nitrosylation strengthened FKBP5 binding to PHLPP (PH domain leucine-rich repeat protein phosphatase) and reduced AKT (serine/threonine kinase) phosphorylation. C339A weakened this interaction and restored AKT activation, whereas PHLPP inhibition with NSC117079 enhanced AKT signaling and angiogenic responses in vitro. CONCLUSIONS: We identify endothelial FKBP5 as a previously unrecognized regulator of poststroke vascular regeneration and establish S-nitrosylation at cysteine 339 as a molecular switch that restrains angiogenesis and functional recovery through PHLPP-dependent inhibition of AKT signaling. Targeting this modification may offer a strategy to enhance vascular repair after ischemic stroke.
引用
- Zhang XY, Xu H, Guo W, et al. S-Nitrosylation of Endothelial FK506-Binding Protein 5 Impairs Angiogenesis via PHLPP-AKT Axis in Ischemic Stroke. Stroke. 2026. PMID: 42663057. doi:10.1161/STROKEAHA.126.056196
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。